Effects of total glycosides from Baishouwu on human breast and prostate cancer cell proliferation

Alternative Therapies in Health and Medicine

Volumn 9, Issue 5, 2003, Pages 62-66

  Wang, Hongyan ^a   Wang, Qianben ^b   Srivastava, Rakesh K ^a   Gong, Shu Sheng ^c   Lao, Lixing ^b   Fondell, Joseph D ^b   Wang, Jiam Bei ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b SCHOOL OF MEDICINE   (United States)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIANDROGEN; ANTINEOPLASTIC AGENT; BAISHOUWU EXTRACT; GLYCOSIDE; PLANT EXTRACT; THYMIDINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAISHOUWU; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CHINESE HERB; CHINESE MEDICINE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG MECHANISM; HERBAL MEDICINE; HORMONE SENSITIVITY; HUMAN; PROSTATE CANCER; REPORTER GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOPHENONES; BREAST NEOPLASMS; CELL DIVISION; DNA FRAGMENTATION; DNA, NEOPLASM; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; MALE; PROSTATIC NEOPLASMS; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0141708045     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Landis SH, Murray T, Boldin S, Wingo PA: Cancer statistics. CA Cancer J Clin. 48: 6-29, 1998.
2. Rowinsky EK, Cazenave LA, Donehower: Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 82(15): 1247-1259, 1990.
3. Kao GD, Devine P: Use of complementary health practice by prostate carcinoma patients undergoing radiation therapy. Cancer. 88(3): 615-619, 2000.
4. Li SZ: HESHOUWU. In: Ben Cao Gang Mu (Compendium of Materia Medica, Chinese). Nanjing, China, Jin Ling Press, 1590, pp37.
5. Li ZZ: HESHOUWU. In: Ben Can Gang Xuan (Guideline of Materia Medica, Chinese). Gansu, China, Gan Su Press, 1678, pp328-336.
6. Gong SS: BAISHOUWU. In: Collection of Materia Medica (Chinese) Vol II. Beijing, China, People Health Press, 1982, pp328-336.
7. Gong SS, Liu CD, Liu SL, Du YR, Kang W, Dong XQ: Studies on constituents of Cynanchum auricalalum Royle ex Wight. (Chinese). Acta Pharmaceutica Sinica 23(4): 276-280, 1988.
8. Zhao J, Han JH, Wang SJ, Hu SK, Gong SS: Antitumor activity of total glycosides extracted from Cynanchum auriculalum Royle ex Wight. (Chinese). Acta Medica Sinica 3(2): 29-32, 1988.
9. Gu LG, Gong SS: Antitumor activity of total glycosides extracted from Cynanchum auricalalum Royle ex Wight. (Chinese). J Beijing College of Traditional Chinese Medicine. 14(3): 32-33, 1991.
10. Gu LG, Gong SS, Tao JD, Liu CH, Zhang L, Zhou Y: Regulating effect of total glycosides extracted from Cynanchum auriculalum Royle ex Wight. on immunosuppression mice (Chinese). J Traditional Chinese Herbal Medicine. 11(11): 50-52, 1986.
11. Zhang Y, G CN, Wang DF, Y BK, Y CZ, Niu JZ, Guo SG, Wang ZG, L GM, Yang MJ: Histological and biochemical study on effect of total glycosides extracted from Cynanchum auriculalum Royle ex Hight. on hemolytic anemia in rat (Chinese). Acta Medica Sinica. 2(1): 25-28, 1987.
12. Wu BQ, Fu CY, Gong SS, Yan RN, Dang Y, Lian G: Stimulating effects of total phosphalipids extracted from Cynanchum auriculalum Royle ex Wight. on rabbit ear hair growth (Chinese). Acta Medica Sinica. 2(3): 29-31, 1987.
13. Mitsuhashi H, Sakurai K, Nomura T, Kawahara N: Constituents of Asclepiadaceae plants. XVII. Components of Cynanchum wilfordi Hemsley. Chem Pharm Bull. 14(7): 712-717, 1966.
14. Labarea G, Paigen K: A simple, rapid and sensitive DNA assay procedure. Anal Biochem. 102: 344-352, 1980.
15. Wang Q, Fondell JD. Generation of a mammalian cell line stably expressing a tetracycline-regulated epitope-tagged human androgen-receptor: implications for steroid hormone receptor research. Aanal Biochem. 289: 217-230, 2001.
16. Srivastava RK, Sasaki CY, Hardwick JM, Longo DL: Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med. 190(2): 253-265, 1999.
17. Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G, Bhalla K: 1-b-D-Arabinofuranosylcytosine-, mitoxantrone- and paclitaxel-induced apoptosis in HL-60 cells: improved methods for detection of internucleosomal DNA fragmentation. Cancer Chemother Pharmacol. 34: 365-371, 1994.
18. Waring P, Kos FJ, Mullbacher A: Apoptosis or programmed cell death. Med Res Rev. 11: 219-223, 1991.
19. Jacobson JS, Workman SB, Kronenberg F: Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol. 18(3): 668-683, 2000.